| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Minai-Azary Jennifer Lynn is a Chief Financial Officer at Context Therapeutics Inc.. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $191K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 6, 2025 | CNTX Context Therapeutics Inc. | Chief Financial Officer | Buy | 40,010 | $0.64 | $25,486.37 | +100.0% | +24.7% | - | |
| Dec 16, 2022 | CNTX Context Therapeutics Inc. | Chief Financial Officer | Buy | 25,000 | $0.74 | $18,500.00 | +166.7% | -8.3% | +32.5% | |
| Aug 17, 2022 | CNTX Context Therapeutics Inc. | Chief Financial Officer | Buy | 15,000 | $1.80 | $27,000.00 | New | -33.3% | -43.9% |